• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

2-(Difluoromethyl)-5-methylpyridine-3-sulfonyl chloride (CAS No. 1806070-15-4): A Comprehensive Overview

2-(Difluoromethyl)-5-methylpyridine-3-sulfonyl chloride (CAS No. 1806070-15-4) is a specialized sulfonyl chloride derivative that has garnered significant attention in the fields of pharmaceutical chemistry and agrochemical research. This compound, characterized by its unique difluoromethyl and methylpyridine substituents, serves as a versatile intermediate in the synthesis of bioactive molecules. Its molecular structure, C7H6ClF2NO2S, offers a balance of reactivity and stability, making it invaluable for drug discovery and material science applications.

The growing interest in fluorinated compounds like 2-(Difluoromethyl)-5-methylpyridine-3-sulfonyl chloride is driven by their ability to enhance the metabolic stability and bioavailability of target molecules. Researchers frequently search for "fluorinated pyridine derivatives" and "sulfonyl chloride applications," reflecting the compound's relevance in modern medicinal chemistry. Its role in the development of kinase inhibitors and antiviral agents aligns with current trends in precision medicine and infectious disease research.

From a synthetic perspective, 2-(Difluoromethyl)-5-methylpyridine-3-sulfonyl chloride is often employed in nucleophilic substitution reactions and cross-coupling methodologies. Its sulfonyl chloride group acts as an excellent leaving group, facilitating the construction of complex heterocyclic scaffolds. This property is particularly valuable in the design of small-molecule therapeutics, where structural diversity is critical for optimizing target engagement and selectivity.

The compound's physicochemical properties—including its solubility in organic solvents like dichloromethane and tetrahydrofuran—make it a practical choice for laboratory-scale synthesis. Analysts often inquire about "handling sulfonyl chlorides" and "storage conditions for fluorinated intermediates," underscoring the need for proper chemical safety protocols. While not classified as hazardous under standard regulations, it requires storage in anhydrous conditions to prevent hydrolysis.

In the agrochemical sector, 2-(Difluoromethyl)-5-methylpyridine-3-sulfonyl chloride has shown promise as a building block for crop protection agents. The difluoromethyl group is known to improve the lipophilicity and pest resistance of active ingredients, addressing global demands for sustainable agriculture. Searches for "fluorine in agrochemicals" and "pyridine-based pesticides" highlight this intersection of chemical innovation and environmental stewardship.

Market analyses reveal increasing procurement of 2-(Difluoromethyl)-5-methylpyridine-3-sulfonyl chloride by contract research organizations (CROs) and specialty chemical suppliers. The compound's patent landscape suggests its utility in proprietary drug development pipelines, particularly for oncology and central nervous system (CNS) disorders. This aligns with industry queries about "novel sulfonamide synthesis" and "fluorine in CNS drugs."

Quality control of 2-(Difluoromethyl)-5-methylpyridine-3-sulfonyl chloride typically involves HPLC purity analysis and 1H/19F NMR characterization. The compound's spectral data (e.g., chemical shifts for the difluoromethyl proton at ~6.1 ppm) are frequently referenced in method development studies. Laboratories often seek "NMR standards for fluorinated compounds" to ensure analytical accuracy.

Emerging applications in PET radiopharmaceuticals leverage the 18F-isotope analogs of this scaffold, connecting it to cutting-edge diagnostic imaging technologies. The rise of "click chemistry in radiopharmacy" searches underscores how 2-(Difluoromethyl)-5-methylpyridine-3-sulfonyl chloride-like structures enable tracer development for Alzheimer's disease and cancer theranostics.

In conclusion, 2-(Difluoromethyl)-5-methylpyridine-3-sulfonyl chloride (CAS No. 1806070-15-4) exemplifies the synergy between structural innovation and applied chemistry. Its multifaceted roles—from pharmaceutical intermediates to agrochemical precursors—reflect the compound's adaptability to diverse scientific challenges. As research into fluorine chemistry and sulfonamide derivatives expands, this molecule will undoubtedly remain a cornerstone of molecular design strategies.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)